224 related articles for article (PubMed ID: 33344453)
1. TNFR2 Is a Crucial Hub Controlling Mesenchymal Stem Cell Biological and Functional Properties.
Beldi G; Bahiraii S; Lezin C; Nouri Barkestani M; Abdelgawad ME; Uzan G; Naserian S
Front Cell Dev Biol; 2020; 8():596831. PubMed ID: 33344453
[TBL] [Abstract][Full Text] [Related]
2. TNFα/TNFR2 signaling pathway: an active immune checkpoint for mesenchymal stem cell immunoregulatory function.
Beldi G; Khosravi M; Abdelgawad ME; Salomon BL; Uzan G; Haouas H; Naserian S
Stem Cell Res Ther; 2020 Jul; 11(1):281. PubMed ID: 32669116
[TBL] [Abstract][Full Text] [Related]
3. Regulatory T cell induction by mesenchymal stem cells depends on the expression of TNFR2 by T cells.
Naserian S; Shamdani S; Arouche N; Uzan G
Stem Cell Res Ther; 2020 Dec; 11(1):534. PubMed ID: 33303019
[TBL] [Abstract][Full Text] [Related]
4. TNFα-TNFR2 signaling pathway in control of the neural stem/progenitor cell immunosuppressive effect: Different experimental approaches to assess this hypothetical mechanism behind their immunological function.
Shamdani S; Uzan G; Naserian S
Stem Cell Res Ther; 2020 Jul; 11(1):307. PubMed ID: 32698887
[TBL] [Abstract][Full Text] [Related]
5. The TNF/TNFR2 signaling pathway is a key regulatory factor in endothelial progenitor cell immunosuppressive effect.
Naserian S; Abdelgawad ME; Afshar Bakshloo M; Ha G; Arouche N; Cohen JL; Salomon BL; Uzan G
Cell Commun Signal; 2020 Jun; 18(1):94. PubMed ID: 32546175
[TBL] [Abstract][Full Text] [Related]
6. TNFα priming through its interaction with TNFR2 enhances endothelial progenitor cell immunosuppressive effect: new hope for their widespread clinical application.
Nouri Barkestani M; Shamdani S; Afshar Bakshloo M; Arouche N; Bambai B; Uzan G; Naserian S
Cell Commun Signal; 2021 Jan; 19(1):1. PubMed ID: 33397378
[TBL] [Abstract][Full Text] [Related]
7. Corrigendum: TNFR2 Is a Crucial Hub Controlling Mesenchymal Stem Cell Biological and Functional Properties.
Beldi G; Bahiraii S; Lezin C; Nouri Barkestani M; Abdelgawad ME; Uzan G; Naserian S
Front Cell Dev Biol; 2021; 9():753407. PubMed ID: 34504846
[TBL] [Abstract][Full Text] [Related]
8. Skin-Derived Mesenchymal Stem Cells Alleviate Atherosclerosis via Modulating Macrophage Function.
Li Q; Sun W; Wang X; Zhang K; Xi W; Gao P
Stem Cells Transl Med; 2015 Nov; 4(11):1294-301. PubMed ID: 26400926
[TBL] [Abstract][Full Text] [Related]
9. Ablation of TNF-alpha receptors influences mesenchymal stem cell-mediated cardiac protection against ischemia.
Tan J; Weil BR; Abarbanell AM; Wang Y; Herrmann JL; Dake ML; Meldrum DR
Shock; 2010 Sep; 34(3):236-42. PubMed ID: 20160664
[TBL] [Abstract][Full Text] [Related]
10. Regulatory-compliant conditions during cell product manufacturing enhance in vitro immunomodulatory properties of infrapatellar fat pad-derived mesenchymal stem/stromal cells.
Kouroupis D; Bowles AC; Greif DN; Leñero C; Best TM; Kaplan LD; Correa D
Cytotherapy; 2020 Nov; 22(11):677-689. PubMed ID: 32723596
[TBL] [Abstract][Full Text] [Related]
11. CD13 promotes mesenchymal stem cell-mediated regeneration of ischemic muscle.
Rahman MM; Subramani J; Ghosh M; Denninger JK; Takeda K; Fong GH; Carlson ME; Shapiro LH
Front Physiol; 2014; 4():402. PubMed ID: 24409152
[TBL] [Abstract][Full Text] [Related]
12. Iberian pig mesenchymal stem/stromal cells from dermal skin, abdominal and subcutaneous adipose tissues, and peripheral blood: in vitro characterization and migratory properties in inflammation.
Calle A; Barrajón-Masa C; Gómez-Fidalgo E; Martín-Lluch M; Cruz-Vigo P; Sánchez-Sánchez R; Ramírez MÁ
Stem Cell Res Ther; 2018 Jul; 9(1):178. PubMed ID: 29973295
[TBL] [Abstract][Full Text] [Related]
13. Differences and similarities between mesenchymal stem cell and endothelial progenitor cell immunoregulatory properties against T cells.
Razazian M; Khosravi M; Bahiraii S; Uzan G; Shamdani S; Naserian S
World J Stem Cells; 2021 Aug; 13(8):971-984. PubMed ID: 34567420
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte-Colony Stimulating Factor-Overexpressing Mesenchymal Stem Cells Exhibit Enhanced Immunomodulatory Actions Through the Recruitment of Suppressor Cells in Experimental Chagas Disease Cardiomyopathy.
Silva DN; Souza BSF; Vasconcelos JF; Azevedo CM; Valim CXR; Paredes BD; Rocha VPC; Carvalho GB; Daltro PS; Macambira SG; Nonaka CKV; Ribeiro-Dos-Santos R; Soares MBP
Front Immunol; 2018; 9():1449. PubMed ID: 30013550
[TBL] [Abstract][Full Text] [Related]
15. The effect of pro-inflammatory cytokines on immunophenotype, differentiation capacity and immunomodulatory functions of human mesenchymal stem cells.
Pourgholaminejad A; Aghdami N; Baharvand H; Moazzeni SM
Cytokine; 2016 Sep; 85():51-60. PubMed ID: 27288632
[TBL] [Abstract][Full Text] [Related]
16. High Aldehyde Dehydrogenase Activity Identifies a Subset of Human Mesenchymal Stromal Cells with Vascular Regenerative Potential.
Sherman SE; Kuljanin M; Cooper TT; Putman DM; Lajoie GA; Hess DA
Stem Cells; 2017 Jun; 35(6):1542-1553. PubMed ID: 28295901
[TBL] [Abstract][Full Text] [Related]
17. Microenvironmental cues enhance mesenchymal stem cell-mediated immunomodulation and regulatory T-cell expansion.
Kadle RL; Abdou SA; Villarreal-Ponce AP; Soares MA; Sultan DL; David JA; Massie J; Rifkin WJ; Rabbani P; Ceradini DJ
PLoS One; 2018; 13(3):e0193178. PubMed ID: 29513756
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells: Identification, phenotypic characterization, biological properties and potential for regenerative medicine through biomaterial micro-engineering of their niche.
Kobolak J; Dinnyes A; Memic A; Khademhosseini A; Mobasheri A
Methods; 2016 Apr; 99():62-8. PubMed ID: 26384580
[TBL] [Abstract][Full Text] [Related]
19. Human Glioblastoma-Derived Mesenchymal Stem Cell to Pericytes Transition and Angiogenic Capacity in Glioblastoma Microenvironment.
Yi D; Xiang W; Zhang Q; Cen Y; Su Q; Zhang F; Lu Y; Zhao H; Fu P
Cell Physiol Biochem; 2018; 46(1):279-290. PubMed ID: 29590646
[TBL] [Abstract][Full Text] [Related]
20. Effect of inflammatory environment on equine bone marrow derived mesenchymal stem cells immunogenicity and immunomodulatory properties.
Barrachina L; Remacha AR; Romero A; Vázquez FJ; Albareda J; Prades M; Ranera B; Zaragoza P; Martín-Burriel I; Rodellar C
Vet Immunol Immunopathol; 2016 Mar; 171():57-65. PubMed ID: 26964718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
